Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 30
Filtrar
Mais filtros

Base de dados
País/Região como assunto
Tipo de documento
Intervalo de ano de publicação
1.
Protein Pept Lett ; 14(8): 784-7, 2007.
Artigo em Inglês | MEDLINE | ID: mdl-17979819

RESUMO

A strong correlation between baking quality and size distribution of wheat glutenin polymers exists, so we have utilized Circular Dichroism Spectroscopy in presence of some denaturant agents to study glutenin polymers. Spectra indicated that all the changes induced by urea and by sodium dodecyl sulphate followed a multi-step transition process.


Assuntos
Glutens/química , Dicroísmo Circular , Conformação Proteica/efeitos dos fármacos , Desnaturação Proteica , Triticum/genética , Ureia/farmacologia
2.
AIDS ; 15(17): 2221-9, 2001 Nov 23.
Artigo em Inglês | MEDLINE | ID: mdl-11698694

RESUMO

OBJECTIVE: To investigate the mechanisms and spectrum of the anti-HIV activity of chloroquine. DESIGN AND METHODS: MT-4 cells or peripheral blood mononuclear cells were infected with X4, R5 or R5/X4 HIV-1 strains from clades A-E and HIV-2. The cells were then treated with clinically relevant and achievable chloroquine concentrations (i.e. 0-12.5 microM), so as to determine the EC50. The effects of chloroquine on reverse transcription and integration were tested using a replication-defective reporter HIV-1 construct (pRRL.sin.hPGK.GFP). The effects of the drug on the viral envelope were assessed by syncytium assays and immunoprecipitation, using antibodies to different epitopes of gp120. RESULTS: In de-novo infected MT-4 cells, chloroquine selectively inhibited HIV-1 IIIB replication but not pRRL.sin.hPGK.GFP. In chronically HIV-1-infected H9 IIIB cells, chloroquine decreased the infectivity of the newly produced virus and the ability of these cells to form syncytia in co-culture with MT-2 cells. These effects were associated with structural changes in the gp120 glycoprotein, such as a reduction of reactivity with antibodies directed against the glycosylated 2G12 epitope. Although affecting a variable target such as gp120, chloroquine was capable of inhibiting X4, R5 and R5/X4 primary HIV-1 isolates from subtypes A, B, C, D, E and HIV-2. CONCLUSION: At clinically achievable concentrations chloroquine inhibits HIV-1 post-integrationally by affecting newly produced viral envelope glycoproteins, and the drug has broad-spectrum anti-HIV-1 and HIV-2 activity.


Assuntos
Fármacos Anti-HIV/farmacologia , Cloroquina/farmacologia , Proteína gp120 do Envelope de HIV/biossíntese , HIV-1/efeitos dos fármacos , HIV-2/efeitos dos fármacos , Fármacos Anti-HIV/toxicidade , Linhagem Celular , Cloroquina/toxicidade , Proteína do Núcleo p24 do HIV/biossíntese , HIV-1/isolamento & purificação , HIV-2/isolamento & purificação , Humanos , Especificidade da Espécie , Replicação Viral/efeitos dos fármacos
3.
J Clin Virol ; 20(3): 131-5, 2001 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-11166661

RESUMO

BACKGROUND: there is a dramatic need for drugs with anti-HIV-1 activity that are affordable for resource-poor countries. Chloroquine (CQ) is one such drug. OBJECTIVES: to review the data indicating that CQ has anti-HIV-1 activity. RESULTS: chloroquine (CQ) and its derivative hydroxychloroquine (HCQ) are endowed with a broad anti-HIV-1 activity inhibiting X4, R5, and X4/R5 stains in lymphocytic and monocytic cells. Interestingly, CQ is capable of inhibiting HIV-1 replication at concentrations within the range reported in plasma of individuals chronically treated with doses of the drug which have well-known and limited toxicity. These effects have been confirmed in vivo in two clinical trials. The principal mechanism of HIV-1 inhibition by CQ seems to be an effect on gp120 on a post-transcriptional level. Because CQ and HCQ appear to have a novel site of action (i.e. post-transcriptional inhibition of gp120), these drugs may be particularly useful in combination with other anti-retroviral agents (e.g. ZDV, ddI and HU). CONCLUSION: combining these drugs with other anti-HIV-1 agents, especially HU and ddI, may be an interesting option for the treatment for HIV-1 infected individuals in the developing world.


Assuntos
Fármacos Anti-HIV/uso terapêutico , Cloroquina/uso terapêutico , Infecções por HIV/tratamento farmacológico , HIV-1/efeitos dos fármacos , Fármacos Anti-HIV/farmacologia , Cloroquina/farmacologia , Proteína gp120 do Envelope de HIV/metabolismo , Humanos , Hidroxicloroquina/farmacologia , Hidroxicloroquina/uso terapêutico , Replicação Viral/efeitos dos fármacos
4.
Diagn Microbiol Infect Dis ; 38(2): 83-6, 2000 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-11035238

RESUMO

The recently introduced automated culture systems MB/BacT (Organon Teknika, Belgium) was compared with radiometric BACTEC 460TB (Becton Dickinson, USA) to test antimicrobial susceptibility of Mycobacterium tuberculosis to first line drugs. On 113 strains 97.5% agreement was obtained, with the difference being not significant. Concordance was practically complete for the most important drugs, isoniazid and rifampin. The two methods however significantly differed for the time needed to complete the test; in fact MB/BacT required on the average five days more than BACTEC 460TB. Despite the delay in the completion of the test, the excellent reliability along with the elimination of radioactivity and full automation make MB/BacT an attractive alternative for susceptibility testing of M. tuberculosis.


Assuntos
Antituberculosos/farmacologia , Testes de Sensibilidade Microbiana/métodos , Mycobacterium tuberculosis/efeitos dos fármacos , Kit de Reagentes para Diagnóstico , Antibióticos Antituberculose/farmacologia , Dióxido de Carbono/metabolismo , Etambutol/farmacologia , Humanos , Isoniazida/farmacologia , Pirazinamida/farmacologia , Rifampina/farmacologia , Sensibilidade e Especificidade , Estreptomicina/farmacologia , Fatores de Tempo
5.
J Biol Regul Homeost Agents ; 10(1): 13-8, 1996.
Artigo em Inglês | MEDLINE | ID: mdl-9049776

RESUMO

The aim of the present study was to assess the possibility that mCD38, a bifunctional ectoenzyme with NAD+ hydrolase and ADP ribose cyclase activities, exerts a protective role in the development of acute, non-syncytial cell death from HIV-1. This hypothesis was tested in a panel of human T-cell lines with defined membrane CD4 (mCD4) expression. A negative correlation was found between the levels of mCD38 expression and the rate of acute cell death from HIV-1 observed 96 h after infection. The negligible rate of cell death from HIV-1 detected in some cell lines (H9 and Supt-1) is apparently unrelated to the level of mCD4 expression, whereas the association with high levels of mCD38 is confirmed. In H9 and Supt-1 cells, the fraction of cells positive to HIV-1 p24 is lower than in the mCD38low cell lines (MT-4, MT-2, C8166). This suggests that high CD38 expression is correlated to resistance to HIV-1 infection, resulting in a lower rate of cell death. A further finding supporting the work hypothesis is that the addition of nicotinamide, a reaction product of CD38, confers to MT-4 cells (mCD38low) partial protection against acute cell death from HIV-1. This indicates that nicotinamide may be at least partially responsible for the correlation observed between high levels of mCD38 and negligible rates of acute cell death from HIV-1.


Assuntos
Antígenos CD , Antígenos de Diferenciação/fisiologia , Apoptose , Linfócitos T CD4-Positivos/enzimologia , Efeito Citopatogênico Viral , HIV-1/fisiologia , N-Glicosil Hidrolases/fisiologia , ADP-Ribosil Ciclase , ADP-Ribosil Ciclase 1 , Linfócitos T CD4-Positivos/citologia , Linfócitos T CD4-Positivos/virologia , Humanos , Imunofenotipagem , Glicoproteínas de Membrana , Niacinamida/fisiologia , Células Tumorais Cultivadas
6.
Panminerva Med ; 39(3): 159-64, 1997 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-9360414

RESUMO

The monocytic/macrophagic lineage has an antigen presenting cell function also towards HIV. On the basis of this fact, a new method, indirect immunofluorescence (IIF) for measurement of p24 from monocytes was used. The results were compared to an amplified enzymatic test for serum dissociated p24 detection in 14 HIV negative individuals at risk for HIV and 12 HIV positive patients. Only one seronegative, who had a symptomatic primary HIV infection, had a positive IIF and also an elevated level of p24 in serum. The others had a negative IIF and, 6 months after the specimen, were not positive to the routine methods for detection of anti-HIV antibodies. Seronegative subjects not at risk for HIV were consistently negative to IIF. Among the HIV positive patients 4 were positive to IIF and the remaining 5 were positive to routine methods. Divergent results could be explained by the fact that one test measures cell derived antigen and the other serum antigen and that monocytes can loose APC function in the advanced stages of the illness. The test proved to be cheap and simple, and it is possible to hypothesize an application of it as a support test for the early diagnosis of HIV infection in laboratories not endowed with high levels of technology. Moreover, the results of the amplified p24 ELISA test in 44 seronegative at risk test are reported herein.


Assuntos
Proteína do Núcleo p24 do HIV/sangue , Infecções por HIV/sangue , Infecções por HIV/diagnóstico , HIV-1 , Leucócitos Mononucleares/química , Ensaio de Imunoadsorção Enzimática , Feminino , Técnica Indireta de Fluorescência para Anticorpo , Humanos , Masculino
7.
J Chemother ; 8(5): 351-7, 1996 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-8957714

RESUMO

Citreoviridin, a mycotoxin produced by some molds of the genera Penicillium and Aspergillus, inhibits the growth of bacteria of the Bacillus genus. Since significant information was not available on the effects of citreoviridin on eukaryotic cells and viruses, this molecule was tested on CD4+ T-lymphoid cell lines, on HIV-1 and on Candida albicans, which sometimes complicates HIV-infection. Antiviral activity was detected in H9 HTLV IIIB cells, a clone chronically infected by HIV-1. Citreoviridin reduced p24 in the supernatant of H9 HTLV IIIB in a dose-dependent manner with a pharmacological selectivity index of 2.6. In C. albicans, the effects of the mold-derivative were evaluated on some parameters associated with pathogenicity and virulence: cellular proliferation, germ tube production, expression of heat shock mannoproteins, release of proteases and phospholipases. At a 12.5 microM dose, citreoviridin showed a marked inhibitory effect on all parameters analyzed. As regards the mechanism of action, it is possible to hypothesize that the effects of citreoviridin may be due to a reduction of protein synthesis, since it inhibited the replication of HIV-1 at post-integrational stages and reduced the intracellular RNA and protein content in C. albicans.


Assuntos
Infecções Oportunistas Relacionadas com a AIDS/tratamento farmacológico , Fármacos Anti-HIV/farmacologia , Aurovertinas/farmacologia , Candida albicans/efeitos dos fármacos , HIV-1/efeitos dos fármacos , Micotoxinas/farmacologia , Linhagem Celular , HIV/efeitos dos fármacos , Humanos , Testes de Sensibilidade Microbiana , Linfócitos T/efeitos dos fármacos , Linfócitos T/microbiologia , Linfócitos T/virologia
8.
Pediatr Med Chir ; 26(3): 191-5, 2004.
Artigo em Italiano | MEDLINE | ID: mdl-16366403

RESUMO

Severe combined immunodeficiencies (SCID) are a group of rare genetic disorders characterized by profoundly defective T lymphocyte. We described in a two months old male a case of SCID with ADA deficiency. With this new case report we summarize recent developments in immunodeficiencies therapy, aiming to induce to bear in mind this disorder, despite its rarity, in differential diagnosis of infections, particularly respiratory or gastrointestinal infections.


Assuntos
Adenosina Desaminase/deficiência , Imunodeficiência Combinada Severa/enzimologia , Humanos , Lactente , Masculino , Imunodeficiência Combinada Severa/diagnóstico , Imunodeficiência Combinada Severa/terapia
9.
Cell Death Dis ; 4: e944, 2013 Dec 05.
Artigo em Inglês | MEDLINE | ID: mdl-24309931

RESUMO

Central memory (T(CM)) and transitional memory (T(TM)) CD4(+) T cells are known to be the major cellular reservoirs for HIV, as these cells can harbor a transcriptionally silent form of viral DNA that is not targeted by either the immune system or current antiretroviral drug regimens. In the present study, we explored the molecular bases of the anti-HIV reservoir effects of auranofin (AF), a pro-oxidant gold-based drug and a candidate compound for a cure of AIDS. We here show that T(CM) and T(TM) lymphocytes have lower baseline antioxidant defenses as compared with their naive counterpart. These differences are mirrored by the effects exerted by AF on T-lymphocytes: AF was able to exert a pro-differentiating and pro-apoptotic effect, which was more pronounced in the memory subsets. AF induced an early activation of the p38 mitogen-activated protein kinase (p38 MAPK) followed by mitochondrial depolarization and a final burst in intracellular peroxides. The pro-differentiating effect was characterized by a downregulation of the CD27 marker expression. Interestingly, AF-induced apoptosis was inhibited by pyruvate, a well-known peroxide scavenger, but pyruvate did not inhibit the pro-differentiating effect of AF, indicating that the pro-apoptotic and pro-differentiating effects involve different pathways. In conclusion, our results demonstrate that AF selectively targets the T(CM)/T(TM) lymphocyte subsets, which encompass the HIV reservoir, by affecting redox-sensitive cell death pathways.


Assuntos
Auranofina/farmacologia , Linfócitos/efeitos dos fármacos , Linfócitos/metabolismo , Apoptose/efeitos dos fármacos , Western Blotting , Linfócitos T CD4-Positivos/metabolismo , Separação Celular , Células Cultivadas , Glutationa/metabolismo , Humanos , Estresse Oxidativo/efeitos dos fármacos , Reação em Cadeia da Polimerase em Tempo Real , Reação em Cadeia da Polimerase Via Transcriptase Reversa , Compostos de Sulfidrila/metabolismo
11.
Quad Sclavo Diagn ; 23(4): 421-4, 1987 Dec.
Artigo em Italiano | MEDLINE | ID: mdl-3508302

RESUMO

In this study an agglutination assay, by a monoclonal antibody coated latex particles, has been used for measuring specifically D-dimer fibrinogen/fibrin concentrations in twenty patients with various thrombotic diseases; the authors have analyzed the test reliability and the possible interferences caused by conditions of specimens collection and preparation.


Assuntos
Produtos de Degradação da Fibrina e do Fibrinogênio/análise , Testes de Fixação do Látex , Anticorpos Monoclonais/análise , Coagulação Intravascular Disseminada/sangue , Coagulação Intravascular Disseminada/diagnóstico , Humanos , Valor Preditivo dos Testes , Embolia Pulmonar/sangue , Embolia Pulmonar/diagnóstico , Tromboflebite/sangue , Tromboflebite/diagnóstico
12.
Mycoses ; 39(3-4): 129-33, 1996.
Artigo em Inglês | MEDLINE | ID: mdl-8767007

RESUMO

Many studies have evaluated the toxicity of mycotoxins to mammals, but there is little information on their action against fungal cells, even although mycotoxins are frequently active against fungi in nature. A crude extract of Aspergillus sulphureus was tested for its growth-inhibitory effect on Cryptococcus neoformans. The reduction in cell growth of Cr. neoformans caused by the extract was dose dependent. Using a liquid medium containing 2% A. sulphureus extract, the RNA content of Cryptococcus amounted to about 60% of that of non-treated cells. Capsule thickening, demonstrated biochemically and with cytological stains, occurred at doses that had minimal effect on cell growth and RNA content. Our results suggest that the virulence of Cr. neoformans may increase in cases of coenobiosis with A. sulphureus, which is theoretically possible in places where corn-fed pigeons are numerous.


Assuntos
Aspergillus , Cryptococcus neoformans/efeitos dos fármacos , Micotoxinas/farmacologia , Parede Celular/efeitos dos fármacos , Corantes , Cryptococcus neoformans/citologia , Cryptococcus neoformans/crescimento & desenvolvimento , RNA Fúngico/análise , Microbiologia do Solo
14.
Neurol Sci ; 23(3): 127-9, 2002 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-12391498

RESUMO

We report the case of a 65-year-old woman who developed symptoms of spinal cord compression due to a spinal meningioma after 10 years of treatment with hydroxyurea (1000 mg/day) for essential thrombocytemia. This case provides a paradigm for the occurrence of symptomatic meningioma in course of HU therapy.


Assuntos
Antineoplásicos/uso terapêutico , Hidroxiureia/uso terapêutico , Neoplasias Meníngeas/tratamento farmacológico , Meningioma/tratamento farmacológico , Medula Espinal/efeitos dos fármacos , Trombocitemia Essencial/complicações , Trombocitemia Essencial/tratamento farmacológico , Idoso , Vértebras Cervicais , Feminino , Humanos , Laminectomia , Imageamento por Ressonância Magnética , Neoplasias Meníngeas/patologia , Neoplasias Meníngeas/fisiopatologia , Meningioma/patologia , Meningioma/fisiopatologia , Medula Espinal/patologia , Medula Espinal/fisiopatologia , Falha de Tratamento , Resultado do Tratamento
15.
Cell Biochem Funct ; 14(4): 291-6, 1996 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-8952048

RESUMO

We have previously demonstrated that fibronectin (FN) can bind HIV-1 envelope proteins, in particular gp 120. The aim of the present study was to determine some biological effects of this phenomenon. Pretreating HIV-1 with human FN increased the infectivity of HIV-1, when a low concentration of the virus was used. In contrast, an RGD-containing pentapeptide (Gly-Arg-Gly-Asp-Ser), which is a fundamental binding site of FN, reduced the infectivity of a suspension of HIV-1 at high concentrations of the virus. It is likely that FN bridges the cell surface and the virions, while the RGD-containing pentapeptide may saturate the HIV-1 binding sites for cell surface receptors. Moreover, gp 120 was bound to the FN present on the surface of platelets. The specificity of this binding was confirmed by the inhibition obtained by pretreating platelets with anti-FN antibodies. The consequence of the surface modifications of the platelets could explain the thrombocytopenia that frequently occurs in patients infected with HIV and suggests also the possibility that platelets could be a vehicle for the virus in the circulation.


Assuntos
Plaquetas/metabolismo , Fibronectinas/metabolismo , Proteína gp120 do Envelope de HIV/metabolismo , HIV-1/metabolismo , Fibronectinas/farmacologia , HIV-1/efeitos dos fármacos , Humanos , Células Tumorais Cultivadas
16.
Clin Chem Lab Med ; 36(4): 205-10, 1998 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-9638344

RESUMO

Gene therapy has enormous potential and could in the near future involve the clinical biochemist in monitoring its efficacy. The involvement of clinical biochemists in this field could be not only in evaluating the impact of a gene-based strategy on disease progression, but also in measuring the expression of the products of therapeutic genes in treated individuals. Indeed, gene therapy presents new possibilities for the treatment of many diseases and, in particular, merits consideration in the treatment of a fatal disease like AIDS. The aim of this paper is to review the biochemical basis and clinical relevance of the gene therapy approaches directed towards the inhibition of human immunodeficiency virus type-1. We discuss the goals which have been achieved, the problems which have occurred and the efforts that are being made to solve them. In this regard, particular attention is paid to new strategies targeting 'therapeutic' enzymes to human immunodeficiency virus type-1 nucleic acids.


Assuntos
Síndrome da Imunodeficiência Adquirida/terapia , Terapia Genética/métodos , Síndrome da Imunodeficiência Adquirida/virologia , Fenômenos Bioquímicos , Bioquímica , Ensaios Clínicos como Assunto , HIV-1/genética , HIV-1/imunologia , HIV-1/fisiologia , Humanos , Imunização , RNA Antissenso/genética , RNA Antissenso/uso terapêutico , Replicação Viral
17.
Quad Sclavo Diagn ; 23(3): 312-7, 1987 Sep.
Artigo em Italiano | MEDLINE | ID: mdl-3503304

RESUMO

Out of 1336 bacterial strains isolated by urine cultures, nearly 23% resulted to be Gram-positives of which 11.8% are Enterococci and 3% Streptococci of Group B. The isolated Enterococci resulted to be sensitive mostly to amoxicillin and resistant to cephalosporins and tetracycline. The authors consequently agree with recent recordings of an accentuated incidence of Enterococci on infections of the urinary tract.


Assuntos
Infecções Estreptocócicas , Infecções Urinárias/etiologia , Feminino , Humanos , Itália , Masculino , Testes de Sensibilidade Microbiana , Fatores Sexuais , Infecções Estreptocócicas/epidemiologia , Infecções Estreptocócicas/microbiologia , Streptococcus/classificação , Streptococcus/efeitos dos fármacos , Streptococcus/isolamento & purificação , Infecções Urinárias/microbiologia
18.
Cell Biochem Funct ; 17(4): 279-87, 1999 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-10587615

RESUMO

Humans with advanced human immunodeficiency virus (HIV) infection present some evidence suggestive of iron accumulation. Ferritin concentrations increase with HIV disease progression, and iron accumulates in several tissues. Iron excess may exert negative effects in individuals with HIV. Indeed, iron accumulation seems to be associated with shorter survival, and a number of investigations point to an iron-mediated oxidative stress in subjects with HIV infection. The observations on humans infected with HIV are in part supported by in-vitro findings. Indeed, in-vitro HIV infection is associated with changes in iron metabolism, and an iron-mediated oxidative stress is likely to contribute to viral cytopathogenicity. Furthermore, it is interesting to point out that the interaction between iron and HIV may be reciprocal, since viruses with a life-cycle involving a DNA phase require chelatable iron for optimum replication. This combined evidence suggests that iron metabolism is an important area for virus/host interaction. These observations may be relevant to both laboratory monitoring and clinical treatment of individuals with HIV.


Assuntos
Infecções por HIV/metabolismo , Ferro/metabolismo , Animais , Progressão da Doença , HIV/fisiologia , Infecções por HIV/sangue , Infecções por HIV/virologia , Humanos , Ferro/sangue , Replicação Viral
19.
Cancer Detect Prev ; 24(1): 46-52, 2000.
Artigo em Inglês | MEDLINE | ID: mdl-10757122

RESUMO

Some effects of recombinant p14, a protein encoded by the tat gene of immunodeficiency virus type 1 (HIV-1), were investigated on T lymphocytic cell cultures. In particular, we detected p14 adsorption to cells, the rate of cell replication, the expression of fibronectin (FN) and its receptor (FNR) and of cell surface CD4 antigen in HIV-1-infected or uninfected MT-4 and H9 cells, treated with p14. Moreover, we evaluated the proportion of apoptotic cells in uninfected and chronically infected H9 cells in the presence of p14 and the modulation of interferon (IFN) production induced by p14 in PBMC of healthy subjects. The results obtained demonstrate that p14 exerts multifunctional activities on HIV-1 infected and uninfected cells. In particular, this protein interacts in a specific manner with cell surface, especially with that of infected cells, and enhances the expression of FN and FNR but not that of the CD4 lymphocyte antigen. Moreover, p14 increases cell replication, IFN production and can exert a slight modulation of apoptosis. We also propose a model to explain a possible role in HIV-1 infection of the effects of exogenous p14.


Assuntos
Linfócitos T CD4-Positivos/efeitos dos fármacos , Produtos do Gene tat/farmacologia , HIV-1/genética , Adsorção , Apoptose/efeitos dos fármacos , Antígenos CD4/metabolismo , Linfócitos T CD4-Positivos/metabolismo , Linfócitos T CD4-Positivos/virologia , Células Cultivadas , DNA/análise , Fibronectinas/metabolismo , Produtos do Gene tat/metabolismo , HIV-1/crescimento & desenvolvimento , Humanos , Interferons/metabolismo , Mitose/efeitos dos fármacos , Receptores de Fibronectina/metabolismo , Proteínas Recombinantes/farmacologia , Produtos do Gene tat do Vírus da Imunodeficiência Humana
20.
Cell Biochem Funct ; 17(1): 35-45, 1999 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-10191507

RESUMO

Because several stimuli of microbial origin enhance the activity of nitric oxide synthase (NOS) in human cells of the myeloid lineage, we decided to investigate whether cellular damage induced by Aspergillus terreus mycotoxins could be associated with an increase in NOS activity. A pool of mycotoxins rather than individual toxins was tested so that the natural conditions could be mimicked. In the present study, we report that a crude extract of A. terreus induces cellular damage and increases NOS activity in K-562 cells, an erythroleukaemic cell line in which NOS is particularly active. The specificity of this association was further investigated by using NOS inhibitors and by comparing, in the same cellular model, the effects of the extract with the activity of other microbial toxins of a defined mechanism of action. Canavanine, an inhibitor of NOS, significantly reduced cell death in the presence of the extract, suggesting that cellular damage, induced by the mycotoxins of A. terreus is at least in part mediated by NOS activity. Moreover, Escherichia coli lipopolysaccharide (LPS), known to be a potent NOS inducer, increased NOS activity in our experimental model as well. In contrast, Bordetella pertussis toxin did not show any effect on NOS activity. The results of this study suggest that NOS may be involved in mycotoxicoses.


Assuntos
Aspergilose/metabolismo , Aspergillus/metabolismo , Células K562/microbiologia , Micotoxinas/toxicidade , Óxido Nítrico Sintase/metabolismo , Canavanina/farmacologia , Morte Celular/efeitos dos fármacos , Sobrevivência Celular/efeitos dos fármacos , Dexametasona/farmacologia , Ativação Enzimática/efeitos dos fármacos , Escherichia coli/metabolismo , Glucocorticoides/farmacologia , Humanos , Ferro/farmacologia , Células K562/citologia , Células K562/enzimologia , Lipopolissacarídeos/toxicidade , Toxina Pertussis , Fatores de Virulência de Bordetella/toxicidade
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA